Lifeway Foods, Inc. — FY2021 Form 10-K
Business context and reporting period. Lifeway Foods produces cultured dairy products, led by drinkable kefir. This filing covers the fiscal year ended December 31, 2021, and includes restated 2020 comparative financial statements and restated quarterly information for 2020 and 2021. It is an annual report, not a standalone fourth-quarter report; the supplied filing text does not provide clear standalone Q4 results.
Financial performance and position
| Metric | FY2021 | FY2020, restated |
|---|---|---|
| Net sales | $119.1 million | $102.0 million |
| Gross profit / margin | $28.7 million / 24.1% | $26.9 million / 26.4% |
| Operating income / margin | $5.9 million / 4.9% | $4.9 million / 4.8% |
| Net income / margin | $3.3 million / 2.8% | $3.2 million / 3.1% |
| Diluted EPS | $0.21 | $0.21 |
| Cash from operations | $5.6 million | $6.4 million |
| Capital expenditures | $1.9 million | $1.9 million |
| Cash and cash equivalents, year-end | $9.2 million | $7.9 million |
Sales rose 16.7%, primarily on higher branded drinkable kefir volumes, with additional contributions from the Glen Oaks acquisition and the USDA Farmers to Families Food Box program. Drinkable kefir other than ProBugs represented 80% of sales. Gross margin declined 2.3 percentage points, mainly reflecting higher milk, ingredient, packaging, and freight costs; pricing actions began in December 2021. Operating margin improved slightly, while net margin declined amid a higher effective tax rate of 41.0%, versus 33.1%.
At year-end, total assets were $70.9 million and total liabilities were $21.7 million. Current assets of $29.0 million exceeded current liabilities of $12.1 million. Debt included $2.8 million drawn on a $5.0 million revolving facility and $4.5 million gross term-loan principal ($4.47 million net of financing costs); $2.2 million remained available on the revolver. The company reported compliance with its financial covenants.
Material changes and notable items
- Glen Oaks acquisition: Lifeway acquired selected assets of the drinkable-yogurt business in August 2021 for $5.8 million, funded with a $5.0 million term loan and existing cash. The acquired business contributed $2.2 million in sales and approximately $0.4 million in pretax income after acquisition.
- Restatement and controls: A historical accounting error from the 2009 Fresh Made acquisition understated both deferred tax liabilities and goodwill by $1.18 million. The correction affected balance-sheet amounts, but not 2020 or 2021 statements of operations, cash flows, stockholders’ equity, or opening 2020 retained earnings. Management identified a material weakness in controls over income-tax accounting and said remediation was underway but could not estimate its completion date.
- Brand-name useful life: Lifeway changed the estimated useful life of an indefinite-lived brand name to 15 years, effective January 1, 2022, beginning amortization thereafter.
- Capital allocation: The company repurchased 250,000 shares for $1.583 million in 2021. No dividends were declared or paid in 2021 or 2020.
- Leadership and related parties: The company terminated Chairperson Ludmila Smolyansky’s consulting agreement effective January 17, 2022. Related-party consulting and royalty payments were $0.5 million and $0.6 million, respectively, in 2021. Former COO Edward Smolyansky’s employment ended January 4, 2022.
Outlook, risks, and contingencies
No specific revenue or earnings guidance is provided. Management said it expected to meet foreseeable liquidity needs through operating cash flows, cash, and the revolving credit facility, while continuing to monitor COVID-19-related uncertainty. Management noted that pandemic-related at-home demand could ease as restrictions recede, and that inflation and competitive conditions may prevent full or timely recovery of input-cost increases.
Key risks include milk and other input-cost volatility, supply-chain and production interruptions, customer concentration (two customers represented approximately 23% of 2021 sales), competition and retailer pricing pressure, and variable-rate debt and covenant requirements. COVID-19 effects on demand, labor, and supply costs remained uncertain. Lifeway disclosed ordinary-course legal matters and said it did not expect them to have a material adverse effect, though outcomes and potential losses could not be estimated with certainty.
The independent auditor issued an unqualified opinion on the financial statements and noted the 2020 restatement. The auditor was not engaged to audit internal controls; management concluded internal control over financial reporting was ineffective because of the material weakness. The auditor reported no critical audit matters.
Most important facts for investors to verify
- Review the material weakness, remediation progress, and subsequent filings for evidence that financial-reporting controls are operating effectively.
- Reconcile cash-flow disclosures: the audited cash-flow statement reports 2021 operating cash flow of $5.564 million and investing outflow of $7.142 million, while the MD&A narrative cites $6.144 million and $7.722 million, respectively. The statement amounts reconcile to the reported $1.307 million net increase in cash.
- Assess whether post-December 2021 pricing actions offset inflation without materially affecting volumes or customer relationships.
- Track acquisition performance, integration, and the amortization and impairment assumptions for acquired intangible assets and goodwill.
- Monitor customer concentration, debt maturities and covenants, and any effect of interest-rate changes on borrowing costs.